Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−3.91 USD
−154.94 M USD
43.95 M USD
58.58 M
About Merus N.V.
Sector
Industry
CEO
Sven Ante Lundberg
Website
Headquarters
Utrecht
Founded
2003
ISIN
NL0011606264
FIGI
BBG00B8LXMS5
Merus NV is a clinical-stage immuno-oncology company, which engages in the discovery and development of bispecific antibody therapeutics. Its pipeline includes Biclonics for solid and hematological tumors. The company was founded by Ton Logtenberg and Hennie Hoogenboom on June 16, 2003 and is headquartered in Utrecht, the Netherlands.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of MRUS is 44.90 USD — it has decreased by −0.07% in the past 24 hours. Watch Merus N.V. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Merus N.V. stocks are traded under the ticker MRUS.
MRUS stock has risen by 1.61% compared to the previous week, the month change is a −13.24% fall, over the last year Merus N.V. has showed a 76.63% increase.
We've gathered analysts' opinions on Merus N.V. future price: according to them, MRUS price has a max estimate of 109.00 USD and a min estimate of 67.00 USD. Watch MRUS chart and read a more detailed Merus N.V. stock forecast: see what analysts think of Merus N.V. and suggest that you do with its stocks.
MRUS reached its all-time high on May 24, 2024 with the price of 61.61 USD, and its all-time low was 7.26 USD and was reached on Jun 23, 2016. View more price dynamics on MRUS chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
MRUS stock is 5.47% volatile and has beta coefficient of 1.44. Track Merus N.V. stock price on the chart and check out the list of the most volatile stocks — is Merus N.V. there?
Today Merus N.V. has the market capitalization of 2.93 B, it has decreased by −1.53% over the last week.
Yes, you can track Merus N.V. financials in yearly and quarterly reports right on TradingView.
Merus N.V. is going to release the next earnings report on Mar 4, 2025. Keep track of upcoming events with our Earnings Calendar.
MRUS earnings for the last quarter are −1.46 USD per share, whereas the estimation was −0.86 USD resulting in a −69.72% surprise. The estimated earnings for the next quarter are −0.96 USD per share. See more details about Merus N.V. earnings.
Merus N.V. revenue for the last quarter amounts to 11.77 M USD, despite the estimated figure of 8.67 M USD. In the next quarter, revenue is expected to reach 9.26 M USD.
MRUS net income for the last quarter is −99.91 M USD, while the quarter before that showed −50.04 M USD of net income which accounts for −99.64% change. Track more Merus N.V. financial stats to get the full picture.
No, MRUS doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 18, 2024, the company has 229.00 employees. See our rating of the largest employees — is Merus N.V. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Merus N.V. EBITDA is −228.46 M USD, and current EBITDA margin is −350.44%. See more stats in Merus N.V. financial statements.
Like other stocks, MRUS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Merus N.V. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Merus N.V. technincal analysis shows the neutral today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Merus N.V. stock shows the buy signal. See more of Merus N.V. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.